When was EMN founded?

EMN was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is EMN located?

EMN is headquartered in Toronto, Canada.

Who is the current CEO of EMN?

Eric J Zimmerman of EMN. They have also founded 1 company.

How many employees does EMN have?

As of Sep 30, 2026, the latest employee count at EMN is 28.

Is EMN a funded company?

EMN is a funded company, having raised a total of $6.2M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 19, 2019.

When was the latest funding round of EMN?

EMN's latest funding was a $***** Series A round on Jan 14, 2025, with participation from 4 investors.

Where does EMN rank among its competitors?

EMN ranks 2nd amongst 73 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was MEND, which secured $9.86M in Feb, 2026.

Who are the top competitors of EMN?

EMN's top competitors include MEND, Interpath Global and Rejuvenate. Among them, MEND secured the most recent funding round in February, 2026.

EMN - 2026 Company Profile, Team, Funding & Competitors

EMN is a series A company based in Toronto (Canada), founded in 2016 by Eric J Zimmerman and Timothy Ormond. It operates as a Developer of clinical-grade nutrition products. EMN has raised $6.2M in funding from investors like dsm-firmenich, Keiretsu Forum and The Kale Fund. The company has 73 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like MEND, Interpath Global and Rejuvenate.

Company Details

Developer of clinical-grade nutrition products. The company's products include PREcovery product is a complex carbohydrate drink mix used to reduce postoperative insulin resistance and improve health. ISOlution product is a clinical-grade whey protein isolate powder used for rehabilitation, wound healing, and managing the protein requirements of ill and aging individuals.

Website: www.emn.health/
Social
Email ID: *****@emnhealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Toronto, Canada

Stage

Series A

Total Funding

$6.2M in 3 rounds

Latest Funding Round

Series A, Jan 14, 2025, $*****

Investors

dsm-firmenich & 8 more

Ranked

2^nd among 73 active competitors

Employee Count

28 as on Sep 30, 2026

Similar Companies

MEND & 76 more

View EMN's full profile

EMN has raised a total funding of $6.2M over 3 rounds. Its first funding round was on Feb 19, 2019. Its latest funding round was a Series A round on Jan 14, 2025 for $*****. 4 investors participated in its latest round. EMN has 9 institutional investors.

Here is the list of recent funding rounds of EMN:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 14, 2025	2988997	Series A	1743045	3412682	1686471	8645970
Oct 30, 2023	9275015	Seed	1235353	1468075	4438888	2873519
Feb 19, 2019	9775184	Seed	6376596	8871639	7664133	8237060

Access funding benchmarks and valuations. Sign up today!

View details of EMN's funding rounds and investors

The founders of EMN are Eric J Zimmerman and Timothy Ormond. Eric J Zimmerman is the CEO of EMN.

Here are the details of EMN's key team members:

Eric J Zimmerman: Co-Founder & CEO of EMN and founder of 1 other company.
Contact Info: 1 email address
Timothy Ormond: Co-Founder of EMN and founder of 1 other company.

View details of EMN's Founder profiles and Board Members

EMN's employee count trend

EMN has 28 employees as of Sep 26. Here is EMN's employee count trend over the years:

Uncover EMN's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EMN include MEND, Interpath Global and Rejuvenate. Here is the list of Top 10 competitors of EMN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MEND 2014, New York City (United States), Series A	Provider of dietary supplements to manage body immunity power	$34.1M	S2G Investments, iSelect Fund & 8 others	60/100
2nd	EMN 2016, Toronto (Canada), Series A	Developer of clinical-grade nutrition products	$6.2M	Ontario Centre of Innovation, Innovation Factory ... & 7 others	42/100
3rd	Interpath Global 1998, Ballarat (Australia), Unfunded	Provider of nutritional supplemnets specializing in joint health	-	-	32/100
4th	Rejuvenate 2018, Burlington (Canada), Unfunded	Provider of an amino acid powder supplement to prevent muscle loss in aging adults	-	-	26/100
5th	Applied Health 1997, Scottsdale (United States), Unfunded	Developer of vitamin & supplement products for treating multiple joint pains	-	-	26/100
6th	Fusion Farm 2013, Viterbo (Italy), Unfunded	Developer of nutritional supplements to support bone and muscle health	-	-	25/100
7th	Physioflexpro 2021, Iceland, Unfunded	Online retailer of supplements formulated for joint comfort and mobility	-	-	24/100
8th	Collagen Msm Plus 2013, Edgware (United Kingdom), Unfunded	Manufactures proprietary joint health formula	-	-	24/100
9th	KLC Biotech 2021, Kartal (Turkey), Unfunded	Manufacturer of intraarticular injections and various nutritional supplement product formulations	-	-	24/100
10th	Arthrem 2011, Wellington (New Zealand), Unfunded	Manufactures natural ingredients based joint health supplement	-	-	24/100